Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The schizophrenia ketamine challenge study debate.

W T Carpenter1

  • 1Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland, Baltimore, USA.

Biological Psychiatry
|October 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxytocin and sexual function in males and females with schizophrenia.

Schizophrenia research·2018
Same author

Concepts and methods when considering negative symptom course.

Psychological medicine·2015
Same author

Attenuated psychosis syndrome: ready for DSM-5.1?

Annual review of clinical psychology·2014
Same author

Another view of the history of antipsychotic drug discovery and development.

Molecular psychiatry·2012
Same author

Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity?

Psychological medicine·2009
Same author

The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.

Psychological medicine·2009
Same journal

Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

Biological psychiatry·2026
Same journal

Remembering Jon-Kar Zubieta, M.D., Ph.D.

Biological psychiatry·2026
Same journal

Kappa opioid receptor availability in borderline personality disorder: An in-vivo investigation with [<sup>11</sup>C]EKAP PET imaging.

Biological psychiatry·2026
Same journal

From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.

Biological psychiatry·2026
Same journal

Distinct and Shared Molecular Mechanisms Underlie Morphological-Functional Overcoupling and Undercoupling in Major Depressive Disorder.

Biological psychiatry·2026
Same journal

Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity.

Biological psychiatry·2026
See all related articles

Ketamine challenge studies in schizophrenia subjects are ethically sound, causing only brief, mild distress. These studies provide valuable insights into schizophrenia pathophysiology without lasting harm.

Area of Science:

  • Psychiatric research ethics
  • Neuroscience of mental illness
  • Clinical trial safety

Background:

  • Challenge studies in psychiatric research, particularly ketamine use in schizophrenia, are ethically debated.
  • Concerns exist regarding acute distress, lasting harm, and informed consent in vulnerable populations.

Purpose of the Study:

  • To analyze the safety and ethical considerations of ketamine challenge studies in schizophrenia.
  • To evaluate the duration and severity of induced psychosis and anxiety, adverse events, and informed consent adequacy.

Main Methods:

  • Review of background ketamine safety data.
  • Qualitative and quantitative analysis of data from North American ketamine challenge studies involving schizophrenia subjects.
  • Assessment of psychosis and anxiety changes, "worst case" experiences, prolonged adverse effects, and informed consent procedures.
Keywords:
Biomedical and Behavioral ResearchEmpirical ApproachMental Health Therapies

Related Experiment Videos

Main Results:

  • Induced psychosis and anxiety were mild to moderate and brief.
  • No evidence of prolonged adverse effects was found.
  • Identified "worst case" incidents were few and successfully managed; informed consent procedures were deemed adequate.

Conclusions:

  • Ketamine challenge studies in schizophrenia meet ethical standards.
  • These studies are conducted without lasting adverse effects, with modest and brief discomfort.
  • The research yields important new knowledge for potential benefit to individuals with schizophrenia.